Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.
Source link
Bayer Shares Surge as Partner Forecasts Sales Growth for Prostate-Cancer Drug
Date:
More like thisRelated
Chinese workers worry over being replaced as they adapt to the growing impact of AI
HONG KONG -- Computer programmer Fei Zhaojun's boss asked...
Frijoles Fire crew member dies after medical emergency
Frijoles Fire crew member dies after medical emergencyA support...
Wade Forster Was Bullied for Loving Country Music in School
Rising country singer Wade Forster isn't exactly shy about...
Chinese Chip Maker YMTC Seeks $4.9 Billion IPO
China’s flagship memory chip maker filed for an initial...